Cue Biopharma, Inc. (LS:A426PN) IPO
IPO
Priced at US$7.50 a share on Dec 14, 2017.
- Price
- US$7.50 a share
- Listing
- CUE on the Nasdaq Capital Market
- Underwriters
- MDB Capital Group, LLC, Feltl and Company · In the order on the cover
Steps
| Step | When |
|---|---|
| Filed publicly | Sep 21, 2017 |
| Amended 5 times | Newest Dec 13, 2017 |
| Shares registered with an exchange | Dec 13, 2017 |
| Declared effective by the SEC | Dec 14, 2017 |
| Final prospectus, with the price | Dec 21, 2017 |
Filings
| Filing | Filed |
|---|---|
| 424B1 · Prospectus | Dec 21, 2017 |
| S-1MEF · Registration of more shares for the same offering | Dec 21, 2017 |
| CERT · Exchange's certificate of listing | Dec 18, 2017 |
| EFFECT · Notice that a registration is effective | Dec 14, 2017 |
| 8-A12B · Registration of shares for listing on an exchange | Dec 13, 2017 |
| CORRESP · Letter to the SEC | Dec 13, 2017 |
| S-1/A · Registration statement, amended | Dec 13, 2017 |
| CORRESP · Letter to the SEC | Dec 11, 2017 |
| S-1/A · Registration statement, amended | Dec 11, 2017 |
| UPLOAD · Letter from the SEC | Dec 6, 2017 |
| S-1/A · Registration statement, amended | Dec 5, 2017 |
| FWP · Free writing prospectus | Dec 5, 2017 |
| CORRESP · Letter to the SEC | Dec 4, 2017 |
| UPLOAD · Letter from the SEC | Nov 30, 2017 |
| CORRESP · Letter to the SEC | Nov 17, 2017 |
| S-1/A · Registration statement, amended | Nov 17, 2017 |
| UPLOAD · Letter from the SEC | Nov 14, 2017 |
| S-1/A · Registration statement, amended | Nov 2, 2017 |
| CORRESP · Letter to the SEC | Nov 1, 2017 |
| UPLOAD · Letter from the SEC | Oct 23, 2017 |
| S-1 · Registration statement | Sep 21, 2017 |
From the cover of the final prospectus (424B1) filed Dec 21, 2017